Clinical Trials Directory

Trials / Completed

CompletedNCT00707057

Ibuprofen Extended-Release Dental Pain Study

Ibuprofen 600 mg Extended-Release (ER) Multiple-Dose Dental Pain Study

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
256 (actual)
Sponsor
SCOLR Pharma, Inc. · Industry
Sex
All
Age
16 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of multiple doses of Ibuprofen 600 mg Extended-Release Tablets in a study of dental pain following extraction of third molar teeth.

Detailed description

This is a single-center, multiple-dose, randomized, placebo-controlled, double-blinded, parallel group trial to evaluate the efficacy and safety of multiple doses of Ibuprofen 600 mg Extended-Release Tablets in a study of dental pain following extraction of third molar teeth. The surgery will consist of surgical extraction of 1-2 impacted third molars, of which one must be a mandibular impaction that is partially impacted in either tissue or bone. Subjects will be stratified according to baseline pain intensity, as rated on an 11-point pain intensity numerical rating scale (PI-NRS)and gender.

Conditions

Interventions

TypeNameDescription
DRUGIbuprofen 600 mg Extended-Release TabletsIbuprofen 600 mg Extended-Release Tablet: One 600 mg tablet taken orally every 12 hours or twice daily (BID). Each dose was administered with at least 6 ounces of water. Dose 1 was administered at hour 0, Dose 2 was administered at hour 12, Dose 3 was administered at hour 24 and Dose 4 was administered at hour 36.
DRUGPlaceboPlacebo: One matching placebo tablet was taken orally every 12 hours or twice daily (BID). Each dose was administered with at least 6 ounces of water. Dose 1 was administered at hour 0, Dose 2 was administered at hour 12, Dose 3 was administered at hour 24 and Dose 4 was administered at hour 36.

Timeline

Start date
2008-06-01
Primary completion
2008-10-01
Completion
2008-10-01
First posted
2008-06-30
Last updated
2011-03-24
Results posted
2011-03-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00707057. Inclusion in this directory is not an endorsement.